Vimarsana
Biggest News Aggregation in the World

Page 3 - While Enzolytics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from While Enzolytics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In While Enzolytics Inc Today - Breaking & Trending Today

Enzolytics, Inc.: Virogentics Inc. Announces Pilot Clinical Trial of ITV-1 at National Center for Endocrinology in Bulgaria and Expansion of Nutraceutical Line - Vimarsana News

Enzolytics, Inc.: Virogentics Inc. Announces Pilot Clinical Trial of ITV-1 at National Center for Endocrinology in Bulgaria and Expansion of Nutraceutical Line

COLLEGE STATION, TX / ACCESSWIRE / May 8, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/).Enzolytics, Inc. (the "Company" or "ENZC"), a drug development biotech company, announced that

Enzolytics, Inc. Finalizing Regulatory Labeling Requirements for Delivery of ITV-1 Treatments for Use in Hospitals in Central and Eastern Africa - Company also Provides Additional Details on the Sale of Biogenysis and Virogentics - Vimarsana News

Enzolytics, Inc. Finalizing Regulatory Labeling Requirements for Delivery of ITV-1 Treatments for Use in Hospitals in Central and Eastern Africa - Company also Provides Additional Details on the Sale of Biogenysis and Virogentics

COLLEGE STATION, TX / ACCESSWIRE / April 21, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/).Enzolytics, Inc. (the "Company" or "ENZC"), a drug development biotech company, announced

Enzolytics, Inc.: Enzolytics Announces Progress in the Development and Patenting of Feline Leukemia Monoclonal Antibodies - Vimarsana News

Enzolytics, Inc.: Enzolytics Announces Progress in the Development and Patenting of Feline Leukemia Monoclonal Antibodies

COLLEGE STATION, TX / ACCESSWIRE / April 4, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/).Enzolytics today announced progress on its ongoing program to produce Monoclonal Antibodies

Enzolytics, Inc.: Enzolytics Announces Preliminary Results of GLP Toxicology Study for its anti-HIV Therapeutic ITV-1 and Production of ITV-1 for Initiation of Registration in Africa - Vimarsana News

Enzolytics, Inc.: Enzolytics Announces Preliminary Results of GLP Toxicology Study for its anti-HIV Therapeutic ITV-1 and Production of ITV-1 for Initiation of Registration in Africa

COLLEGE STATION, TX / ACCESSWIRE / February 8, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/).Enzolytics, Inc. announced today the preliminary results of Toxicology studies of the Company's

Enzolytics, Inc.: Enzolytics to Develop Feline Monoclonal Antibodies - Vimarsana News

Enzolytics, Inc.: Enzolytics to Develop Feline Monoclonal Antibodies

COLLEGE STATION, TX / ACCESSWIRE / January 3, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/).Enzolytics today announced its ongoing efforts to develop fully feline Monoclonal Antibodies.